According to a recent LinkedIn post from Doccla, the company is drawing attention to the use of its Comfort Tracker technology in end-of-life care within the U.K. health system. The post references a Telegraph article following Dr. Rachel Melsom’s work in Sussex, where terminally ill patients are remotely monitored in their final weeks and months.
Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
The LinkedIn post highlights that this virtual monitoring aims to give clinical teams earlier visibility into patients’ conditions and to provide more support for families at home. It also cites survey data that 56% of people would prefer to die at home, suggesting a sizable demand for tools that enable safe and supported home-based end-of-life care.
For investors, the emphasis on Comfort Tracker in community and end-of-life care suggests a potential expansion of Doccla’s addressable market within remote monitoring and virtual care. Integration with NHS and community-care pathways, if scaled, could translate into recurring contracts, stronger payer relationships, and higher barriers to entry for competitors in the U.K. virtual-care space.
The focus on proactive and virtual care also aligns Doccla with broader healthcare system priorities to reduce hospital burden and shift care into the community. If the technology demonstrates clinical and economic value in this sensitive, high-cost segment, it could support future revenue growth and enhance Doccla’s positioning as a partner for publicly funded health systems and community providers.